Profile
QNCX VRTX REGN VRNA ARGX ALNY
Company Name Quince Therapeutics, Inc. Vertex Pharmaceuticals Incorporated Regeneron Pharmaceuticals, Inc. Verona Pharma plc argenx SE Alnylam Pharmaceuticals, Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology
Market Cap $177.07M $122.53B $81.62B $72.68B $50.22B $43.35B
Employees 0.04K 6.10K 15.16K 0.21K 1.60K 2.23K
CEO Dirk Thye Reshma Kewalramani Leonard S. Schleifer David S. Zaccardelli Timothy Van Hauwermeiren Yvonne L. Greenstreet
Ratings
QNCX VRTX REGN VRNA ARGX ALNY
Quant Rating Score 1 4 4 1 4 3
Quant Rating Strong Sell Buy Buy Strong Sell Buy Neutral
Trading
QNCX VRTX REGN VRNA ARGX ALNY
Last Close $1.8 $434.02 $704.31 $106.91 $929.61 $460.54
High 52 $2.16 $513.76 $788 $106.91 $929.61 $491.09
Low 52 $0.84 $366.54 $482.92 $37.86 $532.27 $224.58
Price vs. 52 Week High -16.67 % -15.52 % -10.62 % 0 % 0 % -6.22 %
Price vs. 52 Week Low 114.29 % 18.41 % 45.84 % 182.38 % 74.65 % 105.07 %
Total Return
QNCX VRTX REGN VRNA ARGX ALNY
1 Month Return -3.23 % 4.13 % 21.84 % 0 % 10.19 % -4.39 %
3 Month Return 7.46 % 11.32 % 22.74 % 1.06 % 40.57 % 0.8 %
6 Month Return 111.76 % -1.06 % 18.51 % 49.92 % 64.35 % 61.42 %
9 Month Return 27.66 % -6.08 % 3.57 % 66.4 % 45.48 % 84.22 %
YTD Return -3.74 % 7.78 % -1.13 % 130.21 % 51.16 % 95.72 %
1 Year Return 1.69 % -3.12 % -5.41 % 180.68 % 61.8 % 96.59 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
QNCX VRTX REGN VRNA ARGX ALNY
Dividend Yield Percentage (TTM) - - 0.45 % - - -
Dividend Paid and Capex Coverage Ration (TTM) -80.03 % 9.76 % 3.92 % -147.93 % 65.28 % 5.97 %
Dividend Per Share (TTM) - - 3.52 % - - -
Payout Ratio (TTM) - - 8.22 % - - -
Growth
QNCX VRTX REGN VRNA ARGX ALNY
Asset Growth -36.47 % 7.41 % 53.91 % 10.71 %
Gross Profit Growth - 1.16 % - 26.81 %
Revenue Growth - 0.99 % - 22.97 %
Revenue 3 Year - 20.64 % -15.89 % 147.1 %
Revenue 5 Year - 73.64 % - 775.72 %
Revenue 10 Year - 285.02 % - 2487.4 %
EBIT Growth -33.26 % 9.09 % -131.37 % 24.59 %
Net Income Growth -81.07 % 2.09 % -224.78 % 36.82 %
Net Income 3 Yeari Growth Per Share 56.6 % 6.32 % -148.34 % 69.73 %
Net Income 5 Yeari Growth Per Share 32.4 % 31.91 % 25.82 % 73.13 %
Net Income 10 Yeari Growth Per Share -131.38 % 680.22 % -35.51 % 55.09 %
Operating Income Growth -65.47 % -7.46 % -133.02 % 37.31 %
Operating Cash Flow Growth (CFG) -74.42 % - -143.33 % -107.98 %
Operating 3 Year CFG 65.17 % -100 % -170.73 % 98.8 %
Operating 5 Year CFG 57.82 % -100 % 54.81 % 97.44 %
Operating 10 Year CFG -61.73 % -100 % 40.15 % 97.08 %
EPS Growth -55.95 % 5.31 % -214.81 % 38.07 %
EPS Diluted Growth -55.95 % 8.19 % -208.93 % 38.07 %
Book Value Per Share -69.5 % 32.88 % -22.82 % 129.75 %
Share Holder 3 Year Equity Growth Per Share -82.54 % 41.21 % 1.82 % -89.42 %
Share Holder 5 Year Equity Growth Per Share -88.52 % 191.63 % -24.45 % -96.01 %
Share Holder 10 Year Equity Growth Per Share 174.05 % 842.11 % -71.86 % -95.83 %
Dividend Per Share Growth - - - -
Dividend 3 Year Growth Per Share - - - -
Dividend 5 Year Growth Per Share - - - -
Dividend 10 Year Growth Per Share - - - -
Debt Growth 7.22 % 0.06 % 139.05 % 110.16 %
Free Cash Flow Growth -74.3 % - -144.48 % -201.54 %
Updated On 31 Dec 2024 31 Dec 2025 31 Dec 2024 31 Dec 2024
Profitability
QNCX VRTX REGN VRNA ARGX ALNY
Gross Profit Margin TTM - 86.28 % 86.27 % 95.15 % 65.82 % 83.99 %
Return on Assets TTM -51.85 % 14.78 % 11.11 % -11.01 % 15.06 % 0.9 %
Return on Equity TTM -370.46 % 21.81 % 14.83 % -30.05 % 18.96 % 26.13 %
Return on Capital Employed TTM -55.13 % 19.59 % 10.3 % -8.31 % 5.04 % 8.03 %
Net Income Per EBT TTM 100.13 % 82.61 % 86.12 % 111.64 % 237.3 % -136.38 %
EBT Per Ebit TTM 123.1 % 111.4 % 146.19 % 130.36 % 147.38 % -12.07 %
EBIT Per Revenue TTM - 34.06 % 24.95 % -25.86 % 13.47 % 8.25 %
Cash Flow To Debt Ratio TTM -213.95 % 202.64 % 184 % -29.66 % 932.29 % 9.59 %
Receivables Turnover TTM - 6.02 2.5 1.93 1.91 3.33
Payables Turnover TTM 0.03 0.4 2.1 2.37 0.9 4.37
Inventory Turnover TTM - 0.99 0.62 0.94 2.26 6.82
Fixed Asset Turnover TTM - 388.59 % 280.11 % 6536.22 % 5009.77 % 463.12 %
Asset Turnover TTM - 47.15 % 35.36 % 29.27 % 31.97 % 66.16 %
Operating Cash Flow Per Share TTM -0.71 14.55 48.39 -0.85 5.67 2.02
Free Cash Flow Per Share TTM -0.72 13.06 39.66 -0.85 5.58 1.68
Cash Per Share TTM 48.73 % 2459.7 % 8362.68 % 511.43 % 5536.58 % 2072.79 %
Operating Cash Flow Sales Ratio TTM - 31.71 % 34.71 % -43.23 % 17.54 % 8.28 %
Free Cash Flow Operating Cash Flow Ratio TTM 101.25 % 89.76 % 81.96 % 100.75 % 98.47 % 83.26 %
Cash Flow Coverage Ratios TTM -213.95 % 202.64 % 184 % -29.66 % 932.29 % 9.59 %
Price To Free Cash Flows Ratio TTM -4.54 36.72 20 -995.27 127.92 195.85
Price To Operating Cash Flows Ratio TTM -4.46 32.86 16.23 -126.33 144.41 162.25
Price Cash Flow Ratio TTM -4.46 32.86 16.23 -126.33 144.41 162.25
Income Statement (TTM)
QNCX VRTX REGN VRNA ARGX ALNY
Revenue $0B $11.02B $14.34B $0.03B $2.19B $2.25B
Gross Profit $0B $9.49B $12.24B $0.03B $1.96B $1.92B
Gross Profit Ratio 0% 86.11% 85.35% 93.89% 89.62% 85.62%
EBITDA $-0.04B $0.49B $5.82B $-0.12B $0.11B $-0.18B
Net Income $-0.06B $-0.54B $4.5B $-0.14B $0.83B $-0.28B
EPS Diluted -1.31 -2.08 41.48 -1.73 12.78 -2.18
Balance Sheet (MRQ)
QNCX VRTX REGN VRNA ARGX ALNY
Long Term Debt $0.01B $1.66B $2.71B $0.12B $0.03B $2.59B
Total Liabilities $0.08B $6.12B $9.3B $0.27B $0.7B $4.17B
Total Equity $0.03B $16.41B $31.26B $0.2B $5.5B $0.07B
Total Investments $0.03B $6.65B $16.08B $0.02B $1.93B $1.73B
Total Debt $0.01B $1.75B $2.71B $0.12B $0.04B $2.74B
Total Assets $0.11B $22.53B $40.56B $0.47B $6.2B $4.24B
Cash Flow Statement (TTM)
QNCX VRTX REGN VRNA ARGX ALNY
Net Income $-0.06B $-0.54B $4.5B $-0.17B $0.83B $-0.28B
Inventory $0B $-0.52B $-0.28B $-0.01B $-0.1B $0.01B
Dividends Paid $0B $0B $-0.37B $0B $0B $0B
Operating Cash Flow $-0.03B $-0.49B $4.98B $-0.12B $-0.08B $-0.01B
Capital Expenditure $-0B $-0.3B $-0.9B $-0B $-0.07B $-0.03B
Related Stocks
Ticker Name Price
AADI Aadi Bioscience, Inc. 2.05
AAPG 24.52
AARD Aardvark Therapeutics, Inc. Common Stock 12.65
ABCL AbCellera Biologics Inc. 3.16
ABCM Abcam plc 23.99
ABEO Abeona Therapeutics Inc. 5.13
ABIO ARCA biopharma, Inc. 28.8
ABOS Acumen Pharmaceuticals, Inc. 2.4
ABPWW 0.0155
ABSI Absci Corporation 2.695
ABUS Arbutus Biopharma Corporation 3.84
ABVC ABVC BioPharma, Inc. 1.74
ABVX Abivax SA American Depositary Shares 117.67
ACAD ACADIA Pharmaceuticals Inc. 23.56
ACER Acer Therapeutics Inc. 0.6601
ACET Adicet Bio, Inc. 7.03
ACGN Aceragen, Inc. 0.3849
ACHL Achilles Therapeutics plc 1.48
ACHV Achieve Life Sciences, Inc. 4.25
ACIU AC Immune SA 3.14
ETFs With Exposure to QNCX
Ticker ETF Name Weight Percentage Price
VTI Vanguard Total Stock Market Index Fund 0.00021 340.96
IBB iShares Biotechnology ETF 0 174.98
ITOT iShares Core S&P Total U.S. Stock Market ETF 0 151.14
IWO iShares Russell 2000 Growth ETF 0 339.48
BIB ProShares Ultra Nasdaq Biotechnology 0 86.6578
VXF Vanguard Extended Market Index Fund 0.00185 217.96
IWC iShares Micro-Cap ETF 0.03 168.85
BTEC Principal Healthcare Innovators ETF 0.01 39.49
VUN.TO Vanguard U.S. Total Market Index ETF 0.00021 126.63
VUS.TO Vanguard U.S. Total Market Index ETF (CAD-hedged) 0.00021 118.21
VITNX Vanguard Institutional Total Stock Market Index Fund Institutional Shares 0.00013 114.86
VITPX Vanguard Institutional Total Stock Market Index Fund Institutional Plus Shares 0.00013 114.84
VBAIX Vanguard Balanced Index Fund Institutional Shares 0.00015 52.46
VBIAX Vanguard Balanced Index Fund Admiral Shares 0.00015 52.45
VBINX Vanguard Balanced Index Fund Investor Shares 0.00015 52.45
IEIH iShares Evolved U.S. Innovative Healthcare ETF 0 34.1348
VGRO.TO Vanguard Growth ETF Portfolio 0.00008 44.01
VEQT.TO Vanguard All-Equity ETF Portfolio 0.00009 55.34
VBAL.TO Vanguard Balanced ETF Portfolio 0.00006 37.61
VCNS.TO Vanguard Conservative ETF Portfolio 0.00004 31.94
VCIP.TO Vanguard Conservative Income ETF Portfolio 0.00002 27.22
VRIF.TO Vanguard Retirement Income ETF Portfolio 0.00002 26.82
DFAU Dimensional US Core Equity Market ETF 0 47.92
IBBQ Invesco Nasdaq Biotechnology ETF 0 29.69
VTSAX Vanguard Total Stock Market Index Fund 0.00021 166.03
BTEC.L iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) 0 8.6575
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0.00185 165.43
VITSX Vanguard Total Stock Market Index Fund 0.00021 166.06
SWTSX Schwab Total Stock Market Index Fd Select Shs a Series of Schwab Capit 0.0000391438 16.66
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0.00185 165.44
AVSC Avantis U.S. Small Cap Equity ETF 0 65.27
VTS.AX Vanguard US Total Market Shares Index ETF 0.00021 486.22
VEMPX Vanguard Extended Market Index InstlPlus 0.00185 408.25
VSMPX Vanguard Total Stock Mkt Idx Instl Pls 0.00021 311.51
Unlock